Histone Deacetylase Inhibition Has Targeted Clinical Benefit in <i>ARID1A</i> -Mutated Advanced Urothelial CarcinomaSumati Gupta, Sunil Sharma, Brian K. Dalley et al.|Molecular Cancer Therapeutics|2018Cited by 24
Clinical and translational investigation of pan-HDAC inhibition in advanced urothelial carcinoma (UC).Sumati Gupta, Neeraj Agarwal, Daniel J. Albertson et al.|Journal of Clinical Oncology|2017Cited by 2
Supplemental figure 4 from Histone Deacetylase Inhibition Has Targeted Clinical Benefit in <i>ARID1A</i>-Mutated Advanced Urothelial CarcinomaSumati Gupta, Sunil Sharma, Joshua D. Schiffman et al.|Unknown|2023Cited by 0